Home » US FDA Finalizes Guidance on Imaging Indications
US FDA Finalizes Guidance on Imaging Indications
January 11, 2010
The FDA has issued a final guidance detailing when manufacturers of imaging equipment can avoid changing their product labeling when drugmakers add new
indications to associated imaging drugs or biologics.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor